XJXueqing Jia

Xueqing Jia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xueqing Jia has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Xucheng Wu

    Center for Clinical Big Data and Analytics Second Affiliated Hospital, Department of Big Data in Health Science School of Public Health, Zhejiang Key Laboratory of Intelligent Preventive Medicine, Zhejiang University School of Medicine , Hangzhou 310058

    2 shared publications
  • Zuyun Liu

    Zhejiang University School of Medicine

    2 shared publications
  • Anna Dearman

    University of Essex

    1 shared publication
  • Dan Zhou

    Center for Clinical Big Data and Analytics of the Second Affiliated Hospital and Department of Big Data in Health Science School of Public Health, Zhejiang Key Laboratory of Intelligent Preventive Medicine Zhejiang University School of Medicine Hangzhou 310058 China

    1 shared publication
  • Daniele Bizzarri

    Molecular Epidemiology, LUMC, Leiden, The Netherlands

    1 shared publication
  • Duoduo Fu

    Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA

    1 shared publication

Latest Publications

  • Open Access

    Plasma proteomic signatures of childhood adversity

    by Jiening Yu, Duoduo Fu, Xucheng Wu, Weijing Gao, Hongwei Chen, Xueqing Jia, Fan Pu, Yanjie Zhao, Kaili Sun, Liming Zhang, et al.

  • Open Access

    A Novel Metabolomic Aging Clock Predicting Health Outcomes and Its Genetic and Modifiable Factors

    by Xueqing Jia, Jiayao Fan, Xucheng Wu, Xingqi Cao, Lina Ma, Zeinab Abdelrahman, Fei Zhao, Haitao Zhu, Daniele Bizzarri, Erik B van Den Akker, et al.

    Existing metabolomic clocks exhibit deficiencies in capturing the heterogeneous aging rates among individuals with the same chronological age. Yet, the modifiable and non‐modifiable factors in metabolomic aging have not been systematically studied. Here, a new aging measure—MetaboAgeMort—is developed using metabolomic profiles from 239,291 UK Biobank participants for 10‐year all‐cause mortality prediction. The MetaboAgeMort showed significant associations with all‐cause mortality, cause‐specific mortality, and diverse incident diseases. Adding MetaboAgeMort to a conventional risk factors model improved the predictive ability of 10‐year mortality. A total of 99 modifiable factors across seven categories are identified for MetaboAgeMort. Among these, 16 factors representing pulmonary function, body composition, socioeconomic status, dietary quality, smoking status, alcohol intake, and disease status showed quantitatively stronger associations. The genetic analyses revealed 99 genomic risk loci and 271 genes associated with MetaboAgeMort. The tissue‐enrichment analysis showed significant enrichment in liver. While the external validation of the MetaboAgeMort is required, this study illuminates heterogeneous metabolomic aging across the same age, providing avenues for identifying high‐risk individuals, developing anti‐aging therapies, and personalizing interventions, thus promoting healthy aging and longevity.